Wells Fargo & Company Celldex Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 22,411 shares of CLDX stock, worth $569,015. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,411
Previous 22,736 1.43%
Holding current value
$569,015
Previous $841,000 9.51%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$32.06 - $44.56 $10,419 - $14,482
-325 Reduced 1.43%
22,411 $761,000
Q2 2024

Aug 13, 2024
BUY
$32.76 - $42.56 $36,723 - $47,709
1,121 Added 5.19%
22,736 $841,000
Q1 2024

May 10, 2024
BUY
$35.22 - $51.88 $241,644 - $355,948
6,861 Added 46.5%
21,615 $907,000
Q4 2023

Feb 09, 2024
SELL
$22.61 - $40.65 $612,165 - $1.1 Million
-27,075 Reduced 64.73%
14,754 $585,000
Q3 2023

Nov 13, 2023
SELL
$25.45 - $37.46 $312,322 - $459,709
-12,272 Reduced 22.68%
41,829 $1.15 Million
Q2 2023

Aug 15, 2023
BUY
$30.29 - $38.28 $621,429 - $785,352
20,516 Added 61.09%
54,101 $1.84 Million
Q1 2023

May 12, 2023
BUY
$34.78 - $47.43 $1.13 Million - $1.54 Million
32,538 Added 3107.74%
33,585 $1.21 Million
Q4 2022

Feb 13, 2023
SELL
$27.78 - $45.38 $42,142 - $68,841
-1,517 Reduced 59.17%
1,047 $46,000
Q3 2022

Nov 14, 2022
SELL
$22.7 - $37.57 $5,538 - $9,167
-244 Reduced 8.69%
2,564 $73,000
Q2 2022

Aug 12, 2022
SELL
$20.5 - $37.33 $615,471 - $1.12 Million
-30,023 Reduced 91.45%
2,808 $75,000
Q1 2022

May 16, 2022
SELL
$27.64 - $39.32 $383,670 - $545,800
-13,881 Reduced 29.72%
32,831 $1.12 Million
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $946,483 - $1.49 Million
26,527 Added 131.42%
46,712 $1.81 Million
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $580,042 - $1.12 Million
20,036 Added 13446.98%
20,185 $1.09 Million
Q2 2021

Aug 16, 2021
SELL
$20.71 - $35.37 $414 - $707
-20 Reduced 11.83%
149 $5,000
Q1 2021

May 13, 2021
SELL
$16.19 - $29.91 $798,620 - $1.48 Million
-49,328 Reduced 99.66%
169 $3,000
Q4 2020

Feb 09, 2021
BUY
$14.99 - $22.75 $736,233 - $1.12 Million
49,115 Added 12857.33%
49,497 $866,000
Q3 2020

Nov 05, 2020
BUY
$9.65 - $15.19 $1,264 - $1,989
131 Added 52.19%
382 $6,000
Q2 2020

Aug 13, 2020
SELL
$1.61 - $13.41 $127 - $1,059
-79 Reduced 23.94%
251 $3,000
Q1 2020

May 14, 2020
BUY
$1.55 - $3.07 $511 - $1,013
330 New
330 $0

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.19B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email